PACTR202101875903773已完成未知
The use of topical (Nasal and oropharyngeal) Povidone iodine plus topical Glycyrrhizic acid and oral Glycyrrhizic acid syrup for prevention and treatment of early COVID-19 cases.
Hazem Elsersy0 个研究点目标入组 200 人开始时间: 2021年1月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 6 Year(s) 至 12 Year(s)（—）
- 性别
- All
入选标准
- •COVID-19 PCR positive patients of both genders aging 6 to 70 years having no symptoms or early symptoms such as loss of taste and smell, fever, cough with good O2 saturation.
排除标准
- •Patients with CT evidence category 4 or 5.
- •Patients with dropped O2 saturation below 90 on room air.
- •Patients with uncontrolled hypertension or diabetes mellitus.
- •Ventilated patients or those with multiorgan failure.
研究者
相似试验
进行中（未招募）
不适用
ocal application of Povidone Iodine solution in nose and oral gargle for house hold contacts of COVID19 casesCTRI/2020/06/025928Dr Sumita Shankar
进行中（未招募）
不适用
Efficacy of intranasal administration of haloperidol compared to intramuscular administration in agitated schizophrenic patientsEUCTR2014-001157-17-ESFundació Parc Taulí40
尚未招募
不适用
The Impact of Combined Modality Therapy on Sensorineural Hearing Loss in Patients with Head and Neck CancerSensorineural Hearing LossACTRN12615001300561Phoebe Shorter100
招募中
3 期
Comparison of the efficacy of oral and intranasal midazolam premedication on sedation before undergoing MRI in childrePreanesthetic sedation.Sedative, hypnotic, or anxiolytic related disordersIRCT20151221025641N8Tehran University of Medical Sciences90
尚未招募
4 期
Efficacy Of Intranasal Tapentadol In Pain Management In Opioid Use DisorderCTRI/2021/09/036462GMC RH Patiala